Not applicableStudy completedNCT00797732What this trial is testingA Pilot Study of Acupuncture Treatment for DysphagiaWho this might be right forCarcinomas, Squamous CellDysphagia Dana-Farber Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT01104922What this trial is testingRe-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forSquamous Cell Carcinoma of the Head and Neck David A. Clump, MD, PhD 48
Testing effectiveness (Phase 2)Study completedNCT04474470What this trial is testingEvaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck CancerWho this might be right forSolid Tumor, AdultSquamous Cell Carcinoma of Head and NeckColorectal Adenocarcinoma+3 more TyrNovo Ltd. 52
Not applicableStudy completedNCT00899769What this trial is testingBiomarkers in Patients With Head and Neck Cancer and in Healthy VolunteersWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Ended earlyNCT00720083What this trial is testingChemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 34
Testing effectiveness (Phase 2)Ended earlyNCT04424641What this trial is testingA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more Genmab 48
Not applicableWithdrawnNCT04922112What this trial is testingSleep Apnea in Head and Neck Cancer Patients at the University of ColoradoWho this might be right forObstructive Sleep ApneaSquamous Cell Carcinoma of Head and Neck University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT00004865What this trial is testingCetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin ChemotherapyWho this might be right forHead and Neck Cancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03174275What this trial is testingCarboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell CarcinomaWho this might be right forCarcinoma, Squamous CellOral CancerOropharynx Cancer+3 more UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01181401What this trial is testingInductionChemo-Radio-Antibody-TreatmentWho this might be right forSquamous Cell Carcinoma of the HeadSquamous Cell Carcinoma of the Neck Charite University, Berlin, Germany 94
Testing effectiveness (Phase 2)Ended earlyNCT02540928What this trial is testingAMG 319 in HPV Positive and Negative HNSCCWho this might be right forHuman Papillomavirus (HPV)Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx Cancer Research UK 35
Testing effectiveness (Phase 2)Ended earlyNCT02331875What this trial is testingEfficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral CavityWho this might be right forSquamous Cell Carcinoma of the Oral Cavity Innate Pharma 3
Testing effectiveness (Phase 2)UnknownNCT03913182What this trial is testingApatinib in the Treatment of Recurrence or Metastasis of Esophageal CancerWho this might be right forEsophageal Squamous Cell CarcinomaApatinibRecurrence+1 more Shanghai Chest Hospital 39
Large-scale testing (Phase 3)Study completedNCT00293462What this trial is testingGM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerMucositis OralRadiation Toxicity+1 more Marilyn Dodd 91
Testing effectiveness (Phase 2)Ended earlyNCT05325866What this trial is testingA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionWho this might be right forSolid Tumors Amgen 260
Testing effectiveness (Phase 2)Study completedNCT00022139What this trial is testingRadiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 56
Testing effectiveness (Phase 2)Study completedNCT03226756What this trial is testingNivolumab in Recurrent and/or Metastatic SCCHNWho this might be right forRecurrent and/or Metastatic Platinum-refractory SCCHN UNICANCER 351
Testing effectiveness (Phase 2)Ended earlyNCT03799445What this trial is testingIpilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell CarcinomaWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma+8 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00003251What this trial is testingAmifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerWho this might be right forDrug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity University of Illinois at Chicago 46
Large-scale testing (Phase 3)Study completedNCT00460265What this trial is testingStudy of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forRecurrent and/or Metastatic Head and Neck Cancer Amgen 658